XML 38 R20.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Leases | 12 Months Ended
--- | ---
Dec. 31, 2024
Leases | NOTE 8 – Leases: The components of operating lease cost for the years ended December 31, 2024, 2023 and 2022 were as follows:
|  | Year ended December 31, |  |  | Year ended December 31, |  |  | Year ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | (U.S. $ in millions) |  |  | (U.S. $ in millions) |  |  | (U.S. $ in millions) |
Operating lease cost: |  |  |  |  |  |  |  |  |  |  |  |
Fixed payments and variable payments that depend on an index or rate |  |  | 123 |  |  |  | 132 |  |  |  | 142 |
Variable lease payments not included in the lease liability |  |  | 16 |  |  |  | 5 |  |  |  | 4 |
Short-term lease cost |  |  | 3 |  |  |  | 3 |  |  |  | 2 |
|  | $ | 142 |  |  | $ | 139 |  |  | $ | 148 |
Supplemental cash flow information related to operating leases was as follows:
|  | Year ended December 31, |  |  | Year ended December 31, |  |  | Year ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | (U.S. $ in millions) |  |  | (U.S. $ in millions) |  |  | (U.S. $ in millions) |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Operating cash flows from operating leases |  | $ | 143 |  |  | $ | 141 |  |  | $ | 140 |
Right-of-use assets obtained in exchange for lease obligations (non-cash): |  |  |  |  |  |  |  |  |  |  |  |
Operating leases |  | $ | 137 |  |  | $ | 121 |  |  | $ | 81 |
Supplemental balance sheet information related to operating leases was as follows:
|  | December 31, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
|  | (U.S. $ in millions) |  |  | (U.S. $ in millions) |
Operating leases: |  |  |  |  |  |  |  |
Operating lease ROU assets |  | $ | 367 |  |  | $ | 397 |
Other current liabilities |  |  | 87 |  |  |  | 97 |
Operating lease liabilities |  |  | 296 |  |  |  | 320 |
Total operating lease liabilities |  | $ | 383 |  |  | $ | 417 |
|  | December 31, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Weighted average remaining lease term |  |  |  |  |  |  |  |
Operating leases |  |  | 6.1 years |  |  |  | 6.1 years |
Weighted average discount rate |  |  |  |  |  |  |  |
Operating leases |  |  | 6.5 | % |  |  | 6.0 | %
Maturities of operating lease liabilities were as follows:
|  | December 31, |
|  | 2024 |
|  | (U.S. $ in millions) |
2025 |  |  | 120 |
2026 |  |  | 102 |
2027 |  |  | 81 |
2028 |  |  | 57 |
2029 and thereafter |  |  | 135 |
Total operating lease payments |  | $ | 495 |
Less: imputed interest |  |  | 112 |
Present value of lease liabilities |  | $ | 383 |
As of December 31, 2024, Teva’s total finance lease assets and finance lease liabilities were $ 23 million and $18 million, respectively. As of December 31, 2023, total finance lease assets and finance lease liabilities were $32 million and $23 million, respectively. The difference between those amounts is mainly due to amortization and short - term liabilities.

X
- Definition The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/842-20/tableOfContent + Details
Name: | us-gaap_LesseeOperatingLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration